However, it also emphasizes the need for further research and studies to fully understand the mechanisms by which COX-2 and NSAIDs may be involved in the development and progression of AD and to identify new therapeutic strategies for the management of AD. The gene discussed is PTGS2; the disease is Alzheimer disease.